BioProcessors

Developing a technology, or platform, that is intended to speed up the drug-development process.

Launch date

Oct 2000

Employees

Market cap

Enterprise valuation

Woburn Massachusetts (HQ)

Date	Investors	Amount	Round
Feb 2002	Sequoia Capital Oxford Bioscience Partners	$6.0m	Series A
Jul 2003	HealthCare Ventures HLM Venture Partners New Science Ventures Oxford Bioscience Partners	$13.0m	Series B
Jun 2005	N/A	$6.5m	Series B
Jun 2006	N/A	$18.0m	Series C
Aug 2007	EQT Life Sciences HealthCare Ventures HLM Venture Partners New Science Ventures Oxford Bioscience Partners	$10.0m	Series C
Mar 2009	Seahorse Bioscience	N/A	Acquisition
Total Funding		CAD73.0m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about BioProcessors